Kerala Ayurveda Ltd Stock Price Today (NSE: KERALAYUR)
Fundamental Score
Kerala Ayurveda Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Kerala Ayurveda Ltd share price today is ₹169.80, down 0.03% on NSE/BSE as of 22 September 2026. Kerala Ayurveda Ltd (KERALAYUR) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹220.66 (Cr). The 52-week high for KERALAYUR share price is ₹484.90 and the 52-week low is ₹145.00. The company has a Return on Equity (ROE) of -148.86% and a debt-to-equity ratio of 7.77.
Kerala Ayurveda Ltd Share Price Chart — NSE/BSE Historical Performance
Kerala Ayurveda Ltd share price chart: 11.92% return over the past month. 52-week high ₹484.90, 52-week low ₹145.00.
Kerala Ayurveda Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹170.00 | ₹174.85 | ₹166.55 | ₹169.85 | 8.22K (Cr) | |
| ₹172.15 | ₹175.95 | ₹170.00 | ₹170.80 | 4.13K (Cr) | |
| ₹172.85 | ₹173.00 | ₹166.00 | ₹172.15 | 9.08K (Cr) | |
| ₹173.00 | ₹175.75 | ₹170.10 | ₹172.85 | 8.59K (Cr) | |
| ₹170.05 | ₹176.35 | ₹170.05 | ₹173.40 | 9.87K (Cr) | |
| ₹179.95 | ₹179.95 | ₹172.00 | ₹174.20 | 7.29K (Cr) | |
| ₹172.95 | ₹180.00 | ₹172.95 | ₹176.75 | 5.84K (Cr) | |
| ₹181.90 | ₹181.90 | ₹173.55 | ₹176.10 | 4.58K (Cr) | |
| ₹178.65 | ₹180.00 | ₹171.65 | ₹177.65 | 10.46K (Cr) | |
| ₹182.45 | ₹189.00 | ₹172.45 | ₹173.75 | 20.80K (Cr) |
Kerala Ayurveda Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹172.90 | ₹189.00 | ₹157.30 | ₹169.85 | -1.76% | |
| ₹158.00 | ₹214.40 | ₹145.00 | ₹178.50 | +12.97% | |
| ₹184.90 | ₹187.00 | ₹148.65 | ₹157.40 | -14.87% | |
| ₹199.90 | ₹201.00 | ₹165.00 | ₹185.00 | -7.45% | |
| ₹219.30 | ₹243.00 | ₹193.25 | ₹194.15 | -11.47% | |
| ₹161.80 | ₹257.00 | ₹161.80 | ₹216.65 | +33.90% | |
| ₹200.00 | ₹228.00 | ₹150.00 | ₹157.75 | -21.13% | |
| ₹240.30 | ₹260.10 | ₹196.15 | ₹205.65 | -14.42% | |
| ₹310.55 | ₹340.00 | ₹246.00 | ₹258.30 | -16.82% | |
| ₹369.95 | ₹378.00 | ₹301.35 | ₹315.75 | -14.65% | |
| ₹430.15 | ₹430.15 | ₹333.05 | ₹366.20 | -14.87% | |
| ₹475.00 | ₹484.90 | ₹385.00 | ₹426.05 | -10.31% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Kerala Ayurveda Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Kerala Ayurveda Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of KERALAYUR across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Robust Profit Growth (50.04%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (16.14% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Risk Factors
11 factors identified
Below-Average Return on Equity (-148.86%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-22.62%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-0.38%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
High Price-to-Book Ratio (19.84x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Elevated Debt Levels (D/E: 7.77)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (-1.23x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Liquidity Concerns (Current Ratio: 0.46)
Observation: Current assets may not adequately cover short-term liabilities.
Analysis: Current ratio <1.0 raises working capital concerns.
Negative Free Cash Flow (₹-39.89 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.20%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
High Share Pledging Risk (20.35%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Kerala Ayurveda Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Kerala Ayurveda Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Kerala Ayurveda LtdKerala Ayurveda...Selected✓ KERALAYUR • 530163 | 0/100 | ₹169.80₹170 | ₹220.66₹220.66 | — — | -148.86%Poor -148.86% Poor | -22.62%Poor -22.62% Poor | 7.77Poor 7.8 Poor | — — | 16.14%Excellent 16.14% Excellent | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1864.90₹1865 | ₹447445.46₹447445.46 | 37.00Average 37.0 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9488.00₹9488 | ₹251432.00₹251432.00 | 86.09Average 86.1 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4930.00₹4930 | ₹166860.78₹166860.78 | 78.75Average 78.8 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1127.40₹1127 | ₹112514.52₹112514.52 | 25.13Average 25.1 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1363.10₹1363 | ₹110118.03₹110118.03 | 32.66Average 32.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1937.00₹1937 | ₹104646.43₹104646.43 | 95.61Average 95.6 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1698.90₹1699 | ₹97754.71₹97754.71 | 26.55Average 26.5 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2100.00₹2100 | ₹96022.50₹96022.50 | 17.35Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1145.00₹1145 | ₹95607.50₹95607.50 | 29.59Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2265.00₹2265 | ₹93544.50₹93544.50 | 45.77Average 45.8 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price447445.46 Cr
- Divi's Laboratories Limited share price251432.00 Cr
- Torrent Pharmaceuticals Limited share price166860.78 Cr
- Zydus Lifesciences Limited share price112514.52 Cr
- Cipla Limited share price110118.03 Cr
Kerala Ayurveda Ltd Quarterly Performance
Latest quarterly metrics for KERALAYUR — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
10.91%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
50.04%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
16.14%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Kerala Ayurveda Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for KERALAYUR — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Kerala Ayurveda Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Kerala Ayurveda Ltd (KERALAYUR) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Kerala Ayurveda Ltd
About KERALAYUR (Kerala Ayurveda Ltd)
Kerala Ayurveda Ltd is a pharmaceutical company rooted in the ancient wisdom of Ayurveda, dedicated to crafting authentic and effective health solutions. The company meticulously b...lends traditional Ayurvedic principles with modern scientific advancements to formulate a diverse range of products. These include potent classical medicines meticulously prepared according to time-honored recipes, proprietary formulations developed through rigorous research, and nourishing health supplements. The focus is on providing holistic wellness solutions that address the root cause of imbalances within the body. Kerala Ayurveda Ltd aims to empower individuals to achieve optimal health and vitality through the power of natural healing. The company's product portfolio encompasses a broad spectrum of health and wellness needs. From targeted therapies to address specific ailments, such as pain management and joint care, to comprehensive solutions for overall well-being, Kerala Ayurveda Ltd offers a wide array of options. They cater to the diverse requirements of men, women, and children, offering specialized products for hormonal balance, immune support, and healthy growth. Furthermore, the company understands the impact of lifestyle on health, providing formulations to promote stress relief, cognitive function, and healthy metabolism. The offerings extend beyond internal health, with a line of natural skin, hair, and personal care products that reflect the Ayurvedic philosophy of beauty from within. Kerala Ayurveda Ltd is committed to quality and purity, sourcing the finest herbs and ingredients from sustainable sources. The company adheres to stringent manufacturing standards, ensuring that every product meets the highest levels of efficacy and safety. By combining the ancient knowledge of Ayurveda with modern quality control measures, Kerala Ayurveda Ltd delivers products that are both potent and reliable. The company's unwavering dedication to providing authentic Ayurvedic solutions has made it a trusted name in the pharmaceutical industry.
Company Details
Key Leadership
KERALAYUR Share Price: Frequently Asked Questions
What is the current share price of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd (KERALAYUR) trades at ₹169.80 on NSE and BSE. Market cap ₹220.66 (Cr). Educational data only.
What is the P/E ratio of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd has a P/E of N/Ax vs industry average 34.89x.
What is the Bull Run score for Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Kerala Ayurveda Ltd pay dividends?
Kerala Ayurveda Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd has ROE of -148.86%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd has debt-to-equity of 7.77.
Is Kerala Ayurveda Ltd a good investment?
Bull Run gives Kerala Ayurveda Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.